0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Discovery and Preclinical CRO Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18S12272
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Discovery Preclinical CRO Market Research Report 2022
BUY CHAPTERS

Global Drug Discovery and Preclinical CRO Market Research Report 2025

Code: QYRE-Auto-18S12272
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Discovery and Preclinical CRO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Discovery and Preclinical CRO Market

Drug Discovery and Preclinical CRO Market

The global market for Drug Discovery and Preclinical CRO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery and Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery and Preclinical CRO.
The Drug Discovery and Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery and Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery and Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Discovery and Preclinical CRO Market Report

Report Metric Details
Report Name Drug Discovery and Preclinical CRO Market
CAGR 5%
Segment by Type
Segment by Application
  • Pharmaceutical Company
  • Biotech Company
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv, ChemPartner, JOINN Laboratories, Evotec, Medicilon, Crown Bioscience, Champions Oncology, Frontage Laboratories, Viva Biotech, Hitgen Inc., Shanghai Innostar
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Discovery and Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Discovery and Preclinical CRO Market report?

Ans: The main players in the Drug Discovery and Preclinical CRO Market are Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv, ChemPartner, JOINN Laboratories, Evotec, Medicilon, Crown Bioscience, Champions Oncology, Frontage Laboratories, Viva Biotech, Hitgen Inc., Shanghai Innostar

What are the Application segmentation covered in the Drug Discovery and Preclinical CRO Market report?

Ans: The Applications covered in the Drug Discovery and Preclinical CRO Market report are Pharmaceutical Company, Biotech Company, Others

What are the Type segmentation covered in the Drug Discovery and Preclinical CRO Market report?

Ans: The Types covered in the Drug Discovery and Preclinical CRO Market report are Drug Discovery, Preclinical Research

Recommended Reports

Drug Discovery Services

Cancer Diagnostics & Therapy

Clinical & Diagnostic Tools

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Discovery
1.2.3 Preclinical Research
1.3 Market by Application
1.3.1 Global Drug Discovery and Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotech Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery and Preclinical CRO Market Perspective (2020-2031)
2.2 Global Drug Discovery and Preclinical CRO Growth Trends by Region
2.2.1 Global Drug Discovery and Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery and Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery and Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery and Preclinical CRO Market Dynamics
2.3.1 Drug Discovery and Preclinical CRO Industry Trends
2.3.2 Drug Discovery and Preclinical CRO Market Drivers
2.3.3 Drug Discovery and Preclinical CRO Market Challenges
2.3.4 Drug Discovery and Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery and Preclinical CRO Players by Revenue
3.1.1 Global Top Drug Discovery and Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery and Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery and Preclinical CRO Revenue
3.4 Global Drug Discovery and Preclinical CRO Market Concentration Ratio
3.4.1 Global Drug Discovery and Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery and Preclinical CRO Revenue in 2024
3.5 Global Key Players of Drug Discovery and Preclinical CRO Head office and Area Served
3.6 Global Key Players of Drug Discovery and Preclinical CRO, Product and Application
3.7 Global Key Players of Drug Discovery and Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery and Preclinical CRO Breakdown Data by Type
4.1 Global Drug Discovery and Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery and Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Drug Discovery and Preclinical CRO Breakdown Data by Application
5.1 Global Drug Discovery and Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery and Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery and Preclinical CRO Market Size (2020-2031)
6.2 North America Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery and Preclinical CRO Market Size (2020-2031)
7.2 Europe Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery and Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery and Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery and Preclinical CRO Market Size (2020-2031)
9.2 Latin America Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery and Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Drug Discovery and Preclinical CRO Introduction
11.1.4 Charles River Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Details
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Drug Discovery and Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD
11.5.1 PPD Company Details
11.5.2 PPD Business Overview
11.5.3 PPD Drug Discovery and Preclinical CRO Introduction
11.5.4 PPD Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.5.5 PPD Recent Development
11.6 ICON plc
11.6.1 ICON plc Company Details
11.6.2 ICON plc Business Overview
11.6.3 ICON plc Drug Discovery and Preclinical CRO Introduction
11.6.4 ICON plc Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.6.5 ICON plc Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Drug Discovery and Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Drug Discovery and Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Drug Discovery and Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Laboratories
11.10.1 JOINN Laboratories Company Details
11.10.2 JOINN Laboratories Business Overview
11.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Introduction
11.10.4 JOINN Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.10.5 JOINN Laboratories Recent Development
11.11 Evotec
11.11.1 Evotec Company Details
11.11.2 Evotec Business Overview
11.11.3 Evotec Drug Discovery and Preclinical CRO Introduction
11.11.4 Evotec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.11.5 Evotec Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Drug Discovery and Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champions Oncology
11.14.1 Champions Oncology Company Details
11.14.2 Champions Oncology Business Overview
11.14.3 Champions Oncology Drug Discovery and Preclinical CRO Introduction
11.14.4 Champions Oncology Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.14.5 Champions Oncology Recent Development
11.15 Frontage Laboratories
11.15.1 Frontage Laboratories Company Details
11.15.2 Frontage Laboratories Business Overview
11.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Introduction
11.15.4 Frontage Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.15.5 Frontage Laboratories Recent Development
11.16 Viva Biotech
11.16.1 Viva Biotech Company Details
11.16.2 Viva Biotech Business Overview
11.16.3 Viva Biotech Drug Discovery and Preclinical CRO Introduction
11.16.4 Viva Biotech Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.16.5 Viva Biotech Recent Development
11.17 Hitgen Inc.
11.17.1 Hitgen Inc. Company Details
11.17.2 Hitgen Inc. Business Overview
11.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Introduction
11.17.4 Hitgen Inc. Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.17.5 Hitgen Inc. Recent Development
11.18 Shanghai Innostar
11.18.1 Shanghai Innostar Company Details
11.18.2 Shanghai Innostar Business Overview
11.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Introduction
11.18.4 Shanghai Innostar Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.18.5 Shanghai Innostar Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug Discovery
 Table 3. Key Players of Preclinical Research
 Table 4. Global Drug Discovery and Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Drug Discovery and Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Drug Discovery and Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Drug Discovery and Preclinical CRO Market Share by Region (2020-2025)
 Table 8. Global Drug Discovery and Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Drug Discovery and Preclinical CRO Market Share by Region (2026-2031)
 Table 10. Drug Discovery and Preclinical CRO Market Trends
 Table 11. Drug Discovery and Preclinical CRO Market Drivers
 Table 12. Drug Discovery and Preclinical CRO Market Challenges
 Table 13. Drug Discovery and Preclinical CRO Market Restraints
 Table 14. Global Drug Discovery and Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Drug Discovery and Preclinical CRO Market Share by Players (2020-2025)
 Table 16. Global Top Drug Discovery and Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Preclinical CRO as of 2024)
 Table 17. Ranking of Global Top Drug Discovery and Preclinical CRO Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Drug Discovery and Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Drug Discovery and Preclinical CRO, Headquarters and Area Served
 Table 20. Global Key Players of Drug Discovery and Preclinical CRO, Product and Application
 Table 21. Global Key Players of Drug Discovery and Preclinical CRO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drug Discovery and Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Drug Discovery and Preclinical CRO Revenue Market Share by Type (2020-2025)
 Table 25. Global Drug Discovery and Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Drug Discovery and Preclinical CRO Revenue Market Share by Type (2026-2031)
 Table 27. Global Drug Discovery and Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Drug Discovery and Preclinical CRO Revenue Market Share by Application (2020-2025)
 Table 29. Global Drug Discovery and Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Drug Discovery and Preclinical CRO Revenue Market Share by Application (2026-2031)
 Table 31. North America Drug Discovery and Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Drug Discovery and Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Drug Discovery and Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Drug Discovery and Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Drug Discovery and Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Discovery and Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Drug Discovery and Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Charles River Company Details
 Table 47. Charles River Business Overview
 Table 48. Charles River Drug Discovery and Preclinical CRO Product
 Table 49. Charles River Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 50. Charles River Recent Development
 Table 51. Wuxi AppTec Company Details
 Table 52. Wuxi AppTec Business Overview
 Table 53. Wuxi AppTec Drug Discovery and Preclinical CRO Product
 Table 54. Wuxi AppTec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 55. Wuxi AppTec Recent Development
 Table 56. Labcorp Company Details
 Table 57. Labcorp Business Overview
 Table 58. Labcorp Drug Discovery and Preclinical CRO Product
 Table 59. Labcorp Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 60. Labcorp Recent Development
 Table 61. Eurofins Scientific Company Details
 Table 62. Eurofins Scientific Business Overview
 Table 63. Eurofins Scientific Drug Discovery and Preclinical CRO Product
 Table 64. Eurofins Scientific Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 65. Eurofins Scientific Recent Development
 Table 66. PPD Company Details
 Table 67. PPD Business Overview
 Table 68. PPD Drug Discovery and Preclinical CRO Product
 Table 69. PPD Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 70. PPD Recent Development
 Table 71. ICON plc Company Details
 Table 72. ICON plc Business Overview
 Table 73. ICON plc Drug Discovery and Preclinical CRO Product
 Table 74. ICON plc Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 75. ICON plc Recent Development
 Table 76. Pharmaron Company Details
 Table 77. Pharmaron Business Overview
 Table 78. Pharmaron Drug Discovery and Preclinical CRO Product
 Table 79. Pharmaron Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 80. Pharmaron Recent Development
 Table 81. Inotiv Company Details
 Table 82. Inotiv Business Overview
 Table 83. Inotiv Drug Discovery and Preclinical CRO Product
 Table 84. Inotiv Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 85. Inotiv Recent Development
 Table 86. ChemPartner Company Details
 Table 87. ChemPartner Business Overview
 Table 88. ChemPartner Drug Discovery and Preclinical CRO Product
 Table 89. ChemPartner Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 90. ChemPartner Recent Development
 Table 91. JOINN Laboratories Company Details
 Table 92. JOINN Laboratories Business Overview
 Table 93. JOINN Laboratories Drug Discovery and Preclinical CRO Product
 Table 94. JOINN Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 95. JOINN Laboratories Recent Development
 Table 96. Evotec Company Details
 Table 97. Evotec Business Overview
 Table 98. Evotec Drug Discovery and Preclinical CRO Product
 Table 99. Evotec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 100. Evotec Recent Development
 Table 101. Medicilon Company Details
 Table 102. Medicilon Business Overview
 Table 103. Medicilon Drug Discovery and Preclinical CRO Product
 Table 104. Medicilon Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 105. Medicilon Recent Development
 Table 106. Crown Bioscience Company Details
 Table 107. Crown Bioscience Business Overview
 Table 108. Crown Bioscience Drug Discovery and Preclinical CRO Product
 Table 109. Crown Bioscience Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 110. Crown Bioscience Recent Development
 Table 111. Champions Oncology Company Details
 Table 112. Champions Oncology Business Overview
 Table 113. Champions Oncology Drug Discovery and Preclinical CRO Product
 Table 114. Champions Oncology Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 115. Champions Oncology Recent Development
 Table 116. Frontage Laboratories Company Details
 Table 117. Frontage Laboratories Business Overview
 Table 118. Frontage Laboratories Drug Discovery and Preclinical CRO Product
 Table 119. Frontage Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 120. Frontage Laboratories Recent Development
 Table 121. Viva Biotech Company Details
 Table 122. Viva Biotech Business Overview
 Table 123. Viva Biotech Drug Discovery and Preclinical CRO Product
 Table 124. Viva Biotech Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 125. Viva Biotech Recent Development
 Table 126. Hitgen Inc. Company Details
 Table 127. Hitgen Inc. Business Overview
 Table 128. Hitgen Inc. Drug Discovery and Preclinical CRO Product
 Table 129. Hitgen Inc. Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 130. Hitgen Inc. Recent Development
 Table 131. Shanghai Innostar Company Details
 Table 132. Shanghai Innostar Business Overview
 Table 133. Shanghai Innostar Drug Discovery and Preclinical CRO Product
 Table 134. Shanghai Innostar Revenue in Drug Discovery and Preclinical CRO Business (2020-2025) & (US$ Million)
 Table 135. Shanghai Innostar Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Drug Discovery and Preclinical CRO Picture
 Figure 2. Global Drug Discovery and Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Discovery and Preclinical CRO Market Share by Type: 2024 VS 2031
 Figure 4. Drug Discovery Features
 Figure 5. Preclinical Research Features
 Figure 6. Global Drug Discovery and Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug Discovery and Preclinical CRO Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Company Case Studies
 Figure 9. Biotech Company Case Studies
 Figure 10. Others Case Studies
 Figure 11. Drug Discovery and Preclinical CRO Report Years Considered
 Figure 12. Global Drug Discovery and Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Drug Discovery and Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Drug Discovery and Preclinical CRO Market Share by Region: 2024 VS 2031
 Figure 15. Global Drug Discovery and Preclinical CRO Market Share by Players in 2024
 Figure 16. Global Top Drug Discovery and Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Preclinical CRO as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Drug Discovery and Preclinical CRO Revenue in 2024
 Figure 18. North America Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Drug Discovery and Preclinical CRO Market Share by Country (2020-2031)
 Figure 20. United States Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Drug Discovery and Preclinical CRO Market Share by Country (2020-2031)
 Figure 24. Germany Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Drug Discovery and Preclinical CRO Market Share by Region (2020-2031)
 Figure 32. China Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Drug Discovery and Preclinical CRO Market Share by Country (2020-2031)
 Figure 40. Mexico Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Drug Discovery and Preclinical CRO Market Share by Country (2020-2031)
 Figure 44. Turkey Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Drug Discovery and Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Charles River Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 48. Wuxi AppTec Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 49. Labcorp Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 50. Eurofins Scientific Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 51. PPD Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 52. ICON plc Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 53. Pharmaron Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 54. Inotiv Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 55. ChemPartner Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 56. JOINN Laboratories Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 57. Evotec Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 58. Medicilon Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 59. Crown Bioscience Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 60. Champions Oncology Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 61. Frontage Laboratories Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 62. Viva Biotech Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 63. Hitgen Inc. Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 64. Shanghai Innostar Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart